Published financial brief
21ST10
21ST CENTURY ONCOLOGY HLDGS
- As of
- 2015-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
1 data note
- Input provenance requires review.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20112011-12-31 | FY 20122012-12-31 | FY 20132013-12-31 | FY 20142014-12-31 | FY 20152015-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 644.7 | 694 | 736.5 | 1,018.2 | 1,079.2 |
| Cost of goods soldUSD millions | 446 | 510.8 | 563.5 | 767.2 | 811.5 |
| Selling, general and administrative expenseUSD millions | 89.2 | 92 | 98.3 | 136.3 | 123.3 |
| Depreciation and amortizationUSD millions | 54.1 | 64.9 | 65.2 | 86.6 | 89 |
| Net incomeUSD millions | -353.4 | -154.2 | -80.2 | -357.3 | -134.9 |
| Operating profit (EBIT)USD millions | 55.5 | 26.3 | 9.6 | 28.1 | 55.4 |
| Income taxesUSD millions | -25.4 | 4.5 | -20.4 | 2.3 | 9.7 |
| Short-term debtUSD millions | 14.1 | 11.4 | 17.9 | 26.8 | 1,048.5 |
| Long-term debtUSD millions | 679.2 | 768.2 | 994.5 | 964.4 | 62.6 |
| Cash and equivalentsUSD millions | 10.2 | 15.4 | 21.2 | 106.4 | 66.5 |
| ReceivablesUSD millions | 87.1 | 86.9 | 117 | 126.2 | 127.3 |
| InventoryUSD millions | 4.3 | 3.9 | 4.4 | 3.2 | 3.9 |
| PayablesUSD millions | 27.7 | 27.5 | 57.6 | 62.5 | 59.9 |
| Net property, plant and equipmentUSD millions | 250.1 | 237.3 | 259.6 | 292.1 | 251.2 |
| Capital expenditureUSD millions | 36.6 | 30.7 | 40.7 | 56.7 | 40.9 |
| Operating cash flowUSD millions | 44.8 | 16.1 | -11.6 | -14.8 | 8.4 |
| Prepaid expensesUSD millions | 5.7 | 6 | 7.6 | 8.7 | 7.8 |
| AccrualsUSD millions | 42.6 | 46.4 | 64 | 88.6 | 111.7 |
| EBITDAUSD millions | 109.6 | 91.2 | 74.8 | 114.7 | 144.5 |
| Working capitalUSD millions | 19.9 | 24.3 | 9.1 | 55.8 | -1,015.6 |
| Working capital requirementUSD millions | 63.7 | 63.2 | 63.8 | 66.9 | 71.4 |
| Total debtUSD millions | 693.3 | 779.6 | 1,012.3 | 991.2 | 1,111.1 |
| Free cash flowUSD millions | 8.2 | -14.5 | -52.3 | -71.4 | -32.5 |
| Unlevered free cash flowUSD millions | 48.7 | 61 | 31.4 | 54.9 | 99.1 |
| Returns and ratios | |||||
| ROICratio | 3.5% | 2% | 0.5% | 2% | 4% |
| Pre-tax ROICratio | 3.8% | 2% | 0.6% | 2% | 4% |
| Effective tax rateratio | 6.8% | 0% | 20.7% | 0% | 0% |
| Revenue growthratio | 18.5% | 7.6% | 6.1% | 38.2% | 6% |
| EBIT / Revenueratio | 8.6% | 3.8% | 1.3% | 2.8% | 5.1% |
| Revenue / Invested capitalmultiple | 0.44× | 0.53× | 0.47× | 0.73× | 0.78× |
| Cogs Over Revenuesratio | 69.2% | 73.6% | 76.5% | 75.3% | 75.2% |
| Sga Over Revenuesratio | 13.8% | 13.3% | 13.3% | 13.4% | 11.4% |
| Da Over Revenuesratio | 8.4% | 9.4% | 8.9% | 8.5% | 8.3% |
| Nfa Over Revenuesratio | 38.8% | 34.2% | 35.2% | 28.7% | 23.3% |
| Wcr Over Revenuesratio | 9.9% | 9.1% | 8.7% | 6.6% | 6.6% |
| Debt Over Ebitdamultiple | 6.33× | 8.55× | 13.54× | 8.64× | 7.69× |
| St Debt Over Cashmultiple | 1.39× | 0.74× | 0.84× | 0.25× | 15.77× |
| Interest Over Ebitdamultiple | 0.55× | 0.84× | 1.16× | 0.99× | 0.68× |
| Interest Over Nocf Nicfmultiple | 7.44× | -5.29× | -1.66× | -1.59× | -3.02× |
| Nsf Over Wcrmultiple | 0.06× | -0.06× | -0.05× | -1.19× | 13.76× |
Ask this snapshot
Research assistant
21ST10 · annualSnapshot 2e5ada30
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000